Boardroom Alpha
8-K primary document
CHAR · Current Report (Form 8-K) · Filed July 28, 2026

Charlton Aria Acquisition Corp8-K exhibit

ea029958801ex10-2.htm

Exhibit 10.2

 

Charlton Aria Acquisition Corporation

 

Board of Director Officer Letter

 

July 22, 2026

 

Dear [      ],

 

On behalf of Charlton Aria Acquisition Corporation, a Cayman Islands exempted company (the “Company”), I am pleased to invite you to join the Company’s Board of Directors (the “Board”), effective as of the date hereof (the “Effective Date”). You will serve as a director from the Effective Date until the date upon which you are not re-elected or your earlier removal or resignation.

 

In consideration of your service on the Board and subject to approval by the Board, you will receive the compensation set forth in Schedule I attached hereto.

 

The Company will reimburse you for all reasonable travel expenses that you incur in connection with your attendance at meetings of the Board, in accordance with the Company’s expense reimbursement policy as in effect from time to time. In addition, you will receive indemnification as a director of the Company to the maximum extent extended to directors of the Company generally, as set forth in the Company’s memorandum and articles of association, an indemnification agreement between the Company and you (which will be provided to you upon the Effective Date), and any director and officer insurance the Company may have and maintain from time to time.

 

In accepting this offer, you are representing to us that (i) you do not know of any conflict which would restrict your service on the Board and (ii) you will not provide the Company with any documents, records, or other confidential information belonging to other parties.

 

This letter sets forth the entire compensation you will receive for your service on the Board. Nothing in this letter should be construed as an offer of employment. If the foregoing terms are agreeable, please indicate your acceptance by signing the letter in the space provided below and returning this letter to the Company.

 

  Sincerely,
   
  Charlton Aria Acquisition Corporation
     
  By:  
  Name:  Jung Min Lee
  Title: Chief Executive Officer

 

Accepted and Agreed  
   
Signature:    
Name: [        ]  

 

 

 

 

Schedule I

 

1.You will not receive any cash compensation for your service on the Board. Subject to approval by the Board, you may be granted stock-based compensation, the terms of which (including amount, form, and vesting) will be determined by mutual agreement between you and the Company at a later date.

 

 

 

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer